Illuminati Giulio, Pizzardi Giulia, Pasqua Rocco, Caliò Francesco G, Chakfé Nabil, Ricco Jean-Baptiste
Department of Surgical Sciences, University of Rome, "La Sapienza", Rome, Italy.
Department of Surgical Sciences, University of Rome, "La Sapienza", Rome, Italy.
Ann Vasc Surg. 2019 Jul;58:1-6. doi: 10.1016/j.avsg.2019.02.006. Epub 2019 Apr 19.
No consensus exists on the optimal strategy for treatment of abdominal aortic aneurysm (AAA) associated with colorectal cancer (CRC). The purpose of this study was to evaluate the results of endovascular treatment of AAA with simultaneous resection of CRC.
Twenty-two consecutive patients presenting with AAA associated with a CRC were treated by endovascular AAA exclusion and simultaneous CRC resection. Median diameter of the aneurysm was 6.5 cm (range, 4.8-8 cm). Two patients (9%) had grade I cancer, 5 patients (23%) grade II, 13 patients (59%) grade III, and 2 patients (9%) grade IV. The 2 surgical procedures were performed under the same general anesthesia. Aneurysm exclusion was achieved using an infrarenal aorto-bi-iliac endoprosthesis (13 patients) and using an aorto-bi-iliac endoprosthesis with suprarenal fixation (9 patients), with 1 patient receiving bilateral renal chimney stent implantation. In all cases, vascularization of the hypogastric arteries was preserved. After AAA exclusion, colic resection was carried out by laparotomy with right colectomy (7 patients) and anterior rectocolic resection (15 patients). In all patients, AAA exclusion was controlled by a computed tomographic angioscan (CTA) at 1 month and duplex ultrasound every 6 months, and at some later stage, it was through inclusion of CTA as part of oncology surveillance. The mean duration of follow-up was 42 months (10-120 months). The primary endpoint was composite and regrouped any death occurring during the first 30 days after procedures, any type I endoleak, any aortic reintervention, and any AAA-related mortality.
No patient died during the first 30 postoperative days, and no patient was lost to follow-up. No aortic endoprosthesis infection and no type I endoleak were observed. Five endoleaks arising from the lumbar arteries (n = 4) or from the inferior mesenteric artery (n = 1) were identified. As they were not associated with an increase of the AAA diameter >5 mm, they were not treated. 1 colic anastomotic leak and 2 incisional abscesses were successfully cured by local care only. Nine patients (41%) died of cancer evolution during the follow-up period.
In this series, treatment of AAA and CRC during the same operative session yields results comparable to those observed when surgery is performed in 2 distinct operative sessions. Synchronous treatment reduced waiting time of colic resection. It may also shorten total hospitalization duration, although this last hypothesis is not supported by comparison with a control group.
对于腹主动脉瘤(AAA)合并结直肠癌(CRC)的最佳治疗策略尚无共识。本研究的目的是评估同时行CRC切除的AAA血管内治疗的结果。
连续22例AAA合并CRC患者接受了血管内AAA隔绝术及同期CRC切除术。动脉瘤的中位直径为6.5cm(范围4.8 - 8cm)。2例患者(9%)为I级癌症,5例患者(23%)为II级,13例患者(59%)为III级,2例患者(9%)为IV级。两种手术在相同的全身麻醉下进行。使用肾下主动脉 - 双髂动脉内支架(13例患者)和带肾上固定的主动脉 - 双髂动脉内支架(9例患者)实现动脉瘤隔绝,1例患者接受双侧肾烟囱支架植入。在所有病例中,均保留了髂内动脉的血供。AAA隔绝术后,通过剖腹手术行右半结肠切除术(7例患者)和直肠前切除术(15例患者)进行结肠切除。所有患者在术后1个月通过计算机断层血管造影(CTA)控制AAA隔绝情况,每6个月进行一次双功超声检查,在后期,通过将CTA纳入肿瘤监测的一部分进行检查。平均随访时间为42个月(10 - 120个月)。主要终点是综合的,包括手术后头30天内发生的任何死亡、任何I型内漏、任何主动脉再次干预以及任何与AAA相关的死亡率。
术后30天内无患者死亡,无患者失访。未观察到主动脉内支架感染和I型内漏。发现5例内漏,分别源于腰动脉(4例)或肠系膜下动脉(1例)。由于它们未伴有AAA直径增加>5mm,因此未进行治疗。1例结肠吻合口漏和2例切口脓肿仅通过局部护理成功治愈。9例患者(41%)在随访期间死于癌症进展。
在本系列研究中,在同一手术过程中治疗AAA和CRC的结果与在两个不同手术过程中进行手术的结果相当。同步治疗减少了结肠切除的等待时间。它还可能缩短总住院时间,尽管与对照组比较不支持这最后一个假设。